Collaboration Needed to Make Health Industry Independent
Friday, 16-July-2021 12:10
JAKARTA, NETRALNEWS.COM - The domestic health industry is considered to require collaboration between stakeholders in order to be able to independently meet the needs of the Indonesian health sector.
"Cooperation or collaboration can be carried out in the fields of innovation and research in producing health industry products such as medicines," said Vidjongtius, President Director of PT Kalbe Farma Tbk (IDX:KLBF) at the Investor Daily Summit which was monitored online in Jakarta, on Thursday (07/15/2021).
Research in the health sector in the discovery of drug therapy takes a long time, and thus requires collaboration for acceleration.
"First, it is research innovation to find new molecules and new technologies. If we can't do it ourselves, we can also develop collaborations between universities, businesses, governments and the communities," said Vidjongtius.
- Kendal Regent: Social Affairs Ministry's Social Assistance Programs Help Improve Public Welfare
- Commission VIII Fully Supports Social Affairs Minister's Social Aid Programs for the Poor and Vulnerable
- Social Affairs Minister Encourages Students to Master Technology and Strengthen Collaborations
- Social Affairs Ministry Set to Continue Social Aid Program for People Affected by Pandemic in 2022
He said independence in the domestic health industry requires substantial upstream and downstream investment. Vidjongtius gave an example of the collaboration carried out by Kalbe Farma in clinical trials of immunomodulators for COVID-19 patients.
The clinical trial process can be carried out more quickly through collaboration rather than by research alone. Another collaboration carried out by Kalbe Farma is in the implementation of clinical trials of the COVID-19 GX-19N vaccine.
Secretary General of the Indonesian Ministry of Health Oscar Primadi emphasized the need for the domestic health industry products, such as pharmaceuticals and medical devices, to be developed independently.
This is intended so that Indonesia does not experience dependence on medicinal raw materials that must be imported or medical devices from abroad during a health crisis like today. Oscar emphasized that the government had made various efforts to reduce dependence on imports of medicinal raw materials.
"The COVID-19 crisis situation is a very valuable lesson in which Indonesia can do more than usual. The ability of the pharmaceutical health service industry, domestic medical devices, and pharmaceutical products is one of the essential needs and can guarantee national security," said Oscar.
He said the pharmaceutical and medical device industry in Indonesia has the capacity to boost production to meet the needs of the health sector in Indonesia.
Of the total 19 types of medical devices that are included in the top 10 transactions based on the value and number of products, almost 90 percent of them can be produced domestically, as reported by Antara.
Reporter : turkhan
Editor : turkhan